The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy

CONCLUSION: Airway or blood type 2 inflammation status is not a valid tool for recognizing EPA or predicting asthma exacerbations in asthma patients following controller therapy.PMID:37640656 | DOI:10.1016/j.arbres.2023.07.026
Source: Archivos de Bronconeumologia - Category: Respiratory Medicine Authors: Source Type: research